TipRanks
Go Ultimate55% OFF

Mindbio Therapeutics Corp. (MBIO) Financial Statements

Mindbio Therapeutics Corp. Financial Overview

Mindbio Therapeutics Corp.'s market cap is currently $764.72K. The company's EPS TTM is ―; its P/E ratio is -0.03; Mindbio Therapeutics Corp. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 24Jun 23
Income Statement
Total Revenue――
Gross Profit――
Operating Income$ -55.95K―
EBITDA$ -56.64K$ -4.25M
Net Income$ -415.64K―
Balance Sheet
Cash & Short-Term Investments――
Total Assets$ 194.17K―
Total Debt$ 5.02M$ 0.00
Net Debt$ 4.88M$ 0.00
Total Liabilities$ 5.94M―
Stockholders' Equity――
Cash Flow
Free Cash Flow―$ -2.21M
Operating Cash Flow――
Investing Cash Flow――
Financing Cash Flow――

Currency in USD